Below are the most recent publications written about "Ventricular Function, Left" by people in Profiles.
-
Papapostolou S, Kearns JS, Costello B, O'Brien J, Gutman S, Nanayakkara S, Kaye DM, Walton A, Hare J, Stub D, Taylor A. Relationship between left ventricular wall stress and cardiac remodelling post-TAVR and MitraClip. Open Heart. 2025 Aug 31; 12(2).
-
Rosano GMC, Teerlink JR, Kinugawa K, Bayes-Genis A, Chioncel O, Fang J, Greenberg B, Ibrahim NE, Imamura T, Inomata T, Kuwahara K, Moura B, Onwuanyi A, Sato N, Savarese G, Sakata Y, Sweitzer N, Wilcox J, Yamamoto K, Metra M, Coats AJS. The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS). Eur J Heart Fail. 2025 Jul; 27(7):1174-1187.
-
Loh EW, Huang W, Sultana R, Kong SC, Ng CJ, Tan SY, Chin C, Yap JJL, Yeo KK. Association of blood pressure and left ventricular mass with subclinical coronary atherosclerosis. Open Heart. 2025 Feb 11; 12(1).
-
Lu SR, Zhu Y, Zhou W, Zhang J, Deng YB, Liu YN. Incremental prognostic utility of left ventricular and left atrial strains in coronary artery disease patients with reduced systolic function. Echocardiography. 2024 Jan; 41(1):e15740.
-
Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.
-
Lopez-Candales A, Asif T, Sawalha K, Norgard NB. Heart Failure with Preserved Left Ventricular Ejection Fraction: A Complex Conundrum Simply Not Limited to Diastolic Dysfunction. Cardiovasc Ther. 2023; 2023:1552826.
-
Lopez-Candales A, Norgard NB. Right Here and Right Now: Time to Incorporate Measures of Right Ventricular Function When Assessing Left Heart Failure Clinical Outcomes. J Card Fail. 2022 12; 28(12):1741-1742.
-
Ani C, Shavlik D, Knutsen S, Abudayyeh I, Banta J, O'Brien E, Mentz RJ, Bertoni AG, Fraser G. Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study. BMC Cardiovasc Disord. 2022 04 21; 22(1):186.
-
Gamble FN, Aufan MR, Sharifov OF, Williams LJ, Reighard S, Calhoun DA, Gupta H, Dell'Italia LJ, Denney TS, Lloyd SG. Diastolic function: modeling left ventricular untwisting as a damped harmonic oscillator. Physiol Meas. 2022 03 07; 43(2).
-
Gandotra C, Clark J, Liu Q, Senatore FF, Rose M, Zhang J, Stockbridge NL. Heart Failure Population with Therapeutic Response to Sacubitril/Valsartan, Spironolactone and Candesartan: FDA Perspective. Ther Innov Regul Sci. 2022 01; 56(1):4-7.